Phase 1 Study in Subjects With Tumours Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatin (ADIPemCis) (TRAP Study)
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 26 Feb 2018
At a glance
- Drugs Pegargiminase (Primary) ; Cisplatin; Pemetrexed
- Indications Glioma; Hepatocellular carcinoma; Mesothelioma; Non-small cell lung cancer; Uveal melanoma
- Focus Therapeutic Use
- Acronyms TRAP
- Sponsors Polaris Pharmaceuticals
- 21 Feb 2018 Planned End Date changed from 1 Oct 2019 to 1 Feb 2019.
- 21 Feb 2018 Planned primary completion date changed from 1 Aug 2019 to 1 Dec 2018.
- 21 Feb 2018 Status changed from recruiting to active, no longer recruiting.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History